Kar00 0014 01
Chemical structure of selinexor, the active ingredient in XPOVIO tablets.*
Xpovio Tablet, Film Coated
Product Images NDC 72237-105
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Xpovio (NDC 72237-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Karyopharm Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Kar00 0014 02
A Kaplan-Meier progression free survival curve comparing two treatment arms labeled XVd and Vd over a 28-month period. The x-axis shows time in months, and the y-axis shows progression free survival probability. Patient risk numbers at various time points are displayed below the x-axis for both arms.*
Kar00 0014 03
XPOVIO 60 mg film-coated tablets packaging label by Karyopharm Therapeutics Inc. The label states the dosage as 60 mg taken once weekly, presented in blister packs. Each blister pack contains 3 tablets with 20 mg per tablet. The label includes the NDC number 72237-101-01 and advises dispensing the enclosed Medication Guide with each patient. Additional instructions, manufacturer details, and storage conditions are also provided on the label.*
Kar00 0014 04
Packaging label for XPOVIO (selinexor) tablets, film-coated oral tablets by Karyopharm Therapeutics Inc. This blister pack contains 3 tablets, each with a strength of 20 mg, totaling 60 mg for once weekly dosing. The label includes usage instructions and warnings against breaking or dividing tablets. The product is Rx only.*
Kar00 0014 05
XPOVIO (selinexor) tablets film-coated oral packaging label showing three 20 mg tablets for a total 60 mg dose per pack. Manufactured for Karyopharm Therapeutics Inc., Newton, MA. The label includes instructions to push tablets through foil and swallow whole with water, emphasizing a single 60 mg dose once weekly.*
Kar00 0014 06
Packaging label for XPOVIO (selinexor) tablets, 80 mg strength, oral film-coated tablets. The label indicates the medication is for prescription use only and comes in blister packs for once weekly dosing. Each blister pack contains 16 tablets divided into 4 individual weekly packs, each with 4 tablets of 20 mg per tablet. The labeler is Karyopharm Therapeutics Inc., Newton, MA. The packaging also includes storage instructions and a note that the product is made in France.*
Kar00 0014 07
XPOVIO 80 mg film-coated tablets blister pack label containing 4 tablets for oral use. The label shows instructions to open the pack by pressing and pulling the medication card. The manufacturer is Karyopharm Therapeutics Inc. The pack is marked RX only and emphasizes the 80 mg once weekly dosage.*
Kar00 0014 08
XPOVIO (selinexor) tablets film coated oral dosage unit label showing an 80 mg total dose composed of four 20 mg tablets in a foil blister pack. The label states the manufacturer as Karyopharm Therapeutics Inc and includes instructions to swallow tablets whole with water and to take only one 80 mg dose per week as prescribed by a physician.*
Kar00 0014 09
Packaging label for XPOVIO (selinexor) tablets 60 mg film-coated oral tablets, marketed by Karyopharm Therapeutics Inc. The label indicates the dosage of 60 mg twice weekly (120 mg total weekly dose) in blister packs, each containing 4 individual weekly blister packs with 6 tablets each. The label includes NDC 72237-101-03, uses Rx only, and notes the product is made in France.*
Kar00 0014 10
The image shows a blister pack carton for XPOVIO (selinexor) tablets, 20 mg strength. The label indicates the dosage form as film-coated tablets and the blister pack contains 6 tablets, representing a 60 mg twice weekly dosing schedule (120 mg total weekly dose). Instructions for opening the pack and usage directions are included. The labeler is Karyopharm Therapeutics Inc.*
Kar00 0014 11
XPOVIO (selinexor) film-coated tablet packaging label depicting a 60 mg dose composed of three 20 mg tablets. The label includes instructions to push tablets through foil and swallow whole with water. It is manufactured for Karyopharm Therapeutics Inc., Newton, MA, and indicates dosing guidance and lot/expiration placeholders.*
Kar00 0014 12
Box packaging label for XPOVIO (selinexor) tablets, 80 mg strength. The label indicates blister packs containing four individual weekly blister packs, each with eight tablets (20 mg per tablet), for a total weekly dose of 160 mg. The product is for oral use, prescription only, and manufactured by Karyopharm Therapeutics Inc. The label includes storage instructions and contact information.*
Kar00 0014 13
XPOVIO (selinexor) tablets 80 mg Twice Weekly blister pack containing 8 film-coated tablets (20 mg each) for oral use. The packaging shows instructions to open by pressing and pulling a medication card. It includes warnings not to break, chew, crush, or divide the tablets. Manufactured by Karyopharm Therapeutics Inc.*
Kar00 0014 14
XPOVIO (selinexor) tablets carton label showing a total 80 mg dose composed of four 20 mg film-coated tablets. The label includes instructions to push tablets through foil and to swallow whole with water. It highlights the dosing schedule and manufacturer Karyopharm Therapeutics Inc., Newton, MA.*
Kar00 0014 15
XPOVIO 100 mg once weekly film-coated tablets packaging label for selinexor by Karyopharm Therapeutics Inc. The label indicates blister packs with 4 individual weekly packs containing 5 tablets each (20 mg per tablet). It features the proprietary name XPOVIO and generic name selinexor, NDC 72237-101-05, and emphasizes storage instructions and dispensing of an enclosed Medication Guide.*
Kar00 0014 16
Packaging label for XPOVIO (selinexor) tablets 20 mg oral film-coated tablets in a blister pack containing 5 tablets. The label states a dose of 100 mg once weekly. It includes instructions to press and pull out the medication card to open and indicates the product is manufactured by Karyopharm Therapeutics Inc. The packaging shows a blue round tablet imprinted with 'K20'.*
Kar00 0014 17
XPOVIO (selinexor) 100 mg tablets film-coated oral medication by Karyopharm Therapeutics Inc. The blister pack contains five 20 mg tablets totaling a 100 mg dose. Usage instructions indicate pushing tablets through foil and swallowing whole with water.*
Kar00 0014 18
Packaging label for XPOVIO 40 mg film-coated tablets (selinexor) by Karyopharm Therapeutics Inc. The label indicates a dosing of 40 mg twice weekly (80 mg total weekly dose) in blister packs. It includes details such as NDC 72237-101-06, prescription only, storage conditions, manufacturer information, and a blue tablet image in the center.*
Kar00 0014 19
XPOVIO (selinexor) 40 mg twice weekly blister pack containing 4 film-coated oral tablets (20 mg each) by Karyopharm Therapeutics Inc. The packaging includes instructions to press and pull to open, dosage information, and a blue tablet marked 'K20'.*
Kar00 0014 20
XPOVIO (selinexor) 40 mg film-coated tablets packaging label showing two 20 mg tablets per dose, designed to be pushed through foil. The label includes instructions to swallow tablets whole with water and emphasizes dosing of one 40 mg dose per day, split between Day 1 and Day 3. Manufactured for Karyopharm Therapeutics Inc.*
Kar00 0014 21
XPOVIO 40 mg film-coated tablets packaging label by Karyopharm Therapeutics Inc. This carton is labeled for 40 mg strength, oral route, once weekly blister packs containing 4 blister packs with 2 tablets each (20 mg per tablet). The label includes directions to see prescribing information and medication guide, storage conditions, manufacturer details, and NDC 72237-101-07.*
Kar00 0014 22
Packaging label for XPOVIO (selinexor) tablets, 40 mg strength in a once weekly blister pack format. The label includes instructions to press and pull to open the blister card. It contains 2 tablets, each 20 mg, with directions not to break, chew, crush or divide the tablets. Manufactured by Karyopharm Therapeutics Inc. The label includes a blue tablet imprinted with 'K20'.*
Kar00 0014 23
XPOVIO (selinexor) 40 mg tablets packaging label showing two 20 mg film-coated oral tablets. Label includes dosing instructions emphasizing a single 40 mg dose per week and manufacturer information for Karyopharm Therapeutics Inc., Newton, MA. The label advises swallowing tablets whole with water and pushing tablets through foil.*
Kar00 0014 24
Packaging label for XPOVIO (selinexor) tablets, 40 mg strength, oral film-coated tablets. The label indicates a dosage of 40 mg once weekly in blister packs containing 4 individual weekly blister packs with 1 tablet each. Labeler is Karyopharm Therapeutics Inc., and the product is made in France. The label includes storage information and a note to see prescribing information for dosage and use.*
Kar00 0014 25
Packaging label for XPOVIO (selinexor) tablets, 40 mg strength, oral film-coated tablets. The label shows a blister pack containing one tablet labeled "X 40" and instructions to press and pull to open. It includes dosage form, strength, and directions to not break, chew, crush, or divide the tablet. The labeler is Karyopharm Therapeutics Inc. The package is identified as a 40 mg once weekly blister pack.*
Kar00 0014 26
XPOVIO (selinexor) tablets 40 mg film-coated oral tablet label showing dosage instructions. The label instructs taking only one 40 mg dose once per week as prescribed and includes a foil blister pack image with the tablet dose marked. Manufactured by Karyopharm Therapeutics Inc.*
Kar00 0014 27
XPOVIO 40 mg Twice Weekly selinexor tablets packaging label for blister packs containing 8 film-coated tablets. Label states a total weekly dose of 80 mg and indicates contents of 4 individual weekly blister packs, each with 2 tablets. Manufactured by Karyopharm Therapeutics Inc. The label includes the NDC 72237-102-06 and directions to see prescribing information.*
Kar00 0014 28
XPOVIO 40 mg Twice Weekly blister pack packaging label featuring selinexor tablets. The label shows instructions to press and pull to open the pack containing 2 tablets, each 40 mg, totaling an 80 mg weekly dose. The label is marked Rx only and includes the Karyopharm Therapeutics Inc. logo and name as the labeler.*
Kar00 0014 29
XPOVIO (selinexor) 40 mg film-coated tablets label showing two oval tablets each marked with '40 mg'. The label includes dosage instructions to take a single 40 mg dose per day, specifying doses on Day 1 and Day 3, with directions to push the tablet through foil and swallow whole with water. Manufactured for Karyopharm Therapeutics Inc.*
Kar00 0014 30
The packaging label for XPOVIO 60 mg tablets, with the active ingredient selinexor. These film-coated oral tablets are supplied in blister packs containing 4 individual weekly blister packs, each with 1 tablet. The label includes dosing frequency as once weekly, the NDC 72237-104-01, and is produced by Karyopharm Therapeutics Inc. The label states the product is Rx only and includes storage instructions and a note that the product is made in France.*
Kar00 0014 31
XPOVIO 60 mg film-coated tablets blister pack by Karyopharm Therapeutics Inc. This package contains one oral tablet of selinexor, designed for once weekly dosing. The label includes opening instructions and notes that the blister contains one tablet with 60 mg strength. The packaging is predominantly white with pink accent areas and includes the Karyopharm logo.*
Kar00 0014 32
XPOVIO (selinexor) 60 mg film-coated tablets oral dose label. The label includes dosing instructions emphasizing a single 60 mg dose once per week, pushing the tablet through foil for ingestion with water. Manufactured for Karyopharm Therapeutics Inc., Newton, MA.*
Kar00 0014 33
Packaging label for XPOVIO 80 mg film-coated tablets, containing selinexor as the active ingredient. The label indicates oral tablets packaged in blister packs for once-weekly dosing. The product is Rx only and is labeled by Karyopharm Therapeutics Inc. The label shows information about package contents, dosage form, and manufacturer details, with the product made in France.*
Kar00 0014 34
Packaging label for XPOVIO (selinexor) tablets, 80 mg, oral film-coated tablets in a blister pack containing 2 tablets (40 mg each). The label includes directions for opening the pack, manufacturer Karyopharm Therapeutics Inc., and details that the tablets should not be broken, chewed, crushed, or divided. It also indicates the drug is Rx only and provides storage instructions and dosage guidance to refer to prescribing information.*
Kar00 0014 35
XPOVIO (selinexor) tablets packaging label showing an 80 mg dose consisting of two 40 mg tablets. The label includes dosing instructions to take only one 80 mg dose once per week, pushing tablets through foil and swallowing with water. Manufactured by Karyopharm Therapeutics Inc.*
Kar00 0014 36
Label for XPOVIO (selinexor) 100 mg film-coated tablets in blister packs by Karyopharm Therapeutics Inc. The packaging indicates the dosage form as tablets and strength as 100 mg, taken once weekly. It contains 4 individual weekly blister packs, each with 2 tablets (50 mg each). The label includes storage instructions, manufacturer information, and NDC 72237-103-05.*
Kar00 0014 37
XPOVIO (selinexor) tablets 100 mg oral film-coated tablets blister pack labeled for once weekly dosing. The pack contains 2 tablets of 50 mg strength each. It displays instructions for opening and handling, the NDC 72237-103-15, and is labeled by Karyopharm Therapeutics Inc. The tablets are blue, oval, and marked with X50.*
Kar00 0014 38
Label for XPOVIO (selinexor) tablets by Karyopharm Therapeutics Inc. The label indicates a 100 mg total dose per pack comprised of two 50 mg tablets. Instructions emphasize taking only one 100 mg dose per week as prescribed and swallowing tablets whole with water. Packaging includes lot and expiration placeholders.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
